New Delhi: Zydus Lifesciences on Friday said the US health regulator has granted Orphan Drug Designation to Desidustat, a novel oral product medication for the treatment of Sickle Cell ...
Last Updated:November 20, 2025, 07:00 ISTThe breakthrough was developed by the CSIR–Institute of Genomics and Integrative Biology (IGIB) and was unveiled by Union Minister Dr Jitendra SinghThe therapy, named ...
Sickle cell anaemia tests have become much more affordable, with the government driving the prices of kits to less than Rs 50 in its bid to make diagnosis accessible ...
FDA approval of gene therapies for sickle cell disease: Q&A with NHLBI Director Dr. Gary Gibbons and NHLBI’s Division of Blood Diseases and Resources Director Dr. Julie Panepinto | ...
For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment ...